DocDoc raises $5.45 M for product scaling

DocDoc, Asia's leading patient empowerment company has raised $5.45 million in their latest round of funding.

The financing is led by ADAM (Adamas Finance Asia Limited); a London listed Investment Company who invested $2 million via a convertible bond offering alongside regional family offices and high net worth individuals.

DocDoc leverages the latest in clinical informatics, artificial intelligence and healthcare quality assessment across Asia's largest healthcare provider network to deliver simple yet powerful solutions.

In Asia's healthcare market, the majority of the healthcare decisions are based on recommendations from personal network or arbitrary sources which are not backed by concrete data.

By empowering patients with the relevant data in their time of need, DocDoc aims to connect every patient to the most suitable doctor and thereby resulting in efficiently priced treatments, better outcomes and improved experiences for patients across Asia.

The investment from ADAM will help DocDoc to focus on scaling their doctor discovery product.

The investment was in line with ADAM's strategy providing its shareholders with a diversified pan-Asian portfolio to maximize income and potential capital gain.

Register as Visitor to CPhI China 2018!